MBX Capital

VC New York, United States · Founded 2015

Website

MBX Capital is an early-stage venture capital firm that partners with visionary founders at the convergence of biology, chemistry, AI/ML, robotics, and clinical medicine. The firm focuses on 'deep health' innovations that target the root causes of chronic diseases, environmental exposures, and systemic healthcare inefficiencies.

About MBX Capital

MBX Capital is an investment firm with limited public detail on stated thesis, stage discipline, and check size; the public presence suggests a generalist or family-office-style investor rather than a thesis-driven venture fund. Founders should treat the firm as a flexible-stage participant with checks plausibly in the $250k to $2M range, typically alongside a clear lead. Healthcare exposure is opportunistic at best, with no declared specialization in any clinical, regulatory, or commercial dimension of the sector. Physician founders building software-shape companies with strong commercial traction may find an audience for syndicate participation, but anyone seeking domain-specific value-add or a healthcare lead should pitch a dedicated fund. Geographic posture is most likely US-anchored. The realistic entry path is a warm introduction from an angel or operator within the firm’s existing network; cold outreach via LinkedIn or web form is read but conversion rates are low without prior connection. Founders should be prepared to lead the diligence narrative, arrive with mature commercial signal, and avoid relying on the firm to provide healthcare-specific expertise. Treat MBX Capital as a flexible co-investor rather than a category lead, and ensure round dynamics, valuation, and reserves are anchored by a more specialized partner before signing.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Share your experience

At a glance

Type VC

Stages Seed, Series A

Check size $1M-$5M

Sub-verticals AI/ML in Healthcare, Biotech, Care Delivery / Tech-Enabled Services

HQ New York, United States

Founded 2015

Visit website

Healthcare AI tools backed by MBX Capital

Tools made by companies in MBX Capital's portfolio that we cover in the directory.

Arine Medication Intelligence

Arine

Pharmacology & Dosing AI

Arine leverages AI to provide a medication intelligence platform for comprehensive medication management, adverse event prediction, and optimization of drug regimens for health plans and providers, demonstrating significant improvements in health outcomes and cost reduction.

Not disclosed

Arine

Patient Engagement & Education

Arine's AI-powered platform identifies and supports members most at risk of medication-related problems before they experience negative health events, delivering tailored, proactive interventions to improve clinical outcomes and reduce costs of care across entire populations.

Contact for pricing